While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has recently completed a clinical study titled A ...

The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the ...

U.S. heart disease mortality has dropped 66% since 1970, mainly due to fewer ischemic heart disease deaths. However, deaths ...

Shares of Rocket Pharmaceuticals Inc (NASDAQ:RCKT) advanced 2.4% after the company announced that the U.S. Food and Drug ...

There was discussion at ESC whether Kerendia should be used in place of the SGLT2 inhibitors, or in combination, given that all the benefits of the drug were tied to improvements in heart failure ...

Heart transplantation remains the optimal long-term treatment for appropriate patients with advanced heart failure. However, the donor heart shortage is a limiting factor, and the risk profile of ...

Cite this: Drug Absorption in the Management of Congestive Heart Failure: Loop Diuretics - Medscape - Sep 01, 2003. Abstract and Introduction Systemic Absorption ...

A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA, shortly after it showed preliminary signs of efficacy in a phase 1 trial.

Sarfez Pharmaceuticals, founded by Indian American Salim Shah, received FDA approval for its Soaanz drug, which treats patients suffering from heart failure and renal disease. (ascthem.com photo ...

Incidence and prevalence of heart failure are particularly common with advancing age, with notoriously grim prognoses. The absolute number of heart failure patients will undoubtedly surge as the ...

The primary endpoint of change in heart failure at 8 months did not differ by treatment group, with improvements in 56% in both groups, unchanged in 15% of the placebo group and 19% of the ...